TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
TELA on Nasdaq
Shares outstanding
44,542,200
Price per share
$0.98
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
27,571,223
Total reported value
$32,485,316
% of total 13F portfolios
0%
Share change
+3,988,270
Value change
+$4,138,171
Number of holders
40
Price from insider filings
$0.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EW HEALTHCARE PARTNERS FUND 2, L.P. 17% $11,572,064 7,714,709 EW Healthcare Partners Fund 2 GP, L.P. 17 Nov 2025
Nantahala Capital Management, LLC 13% +29% $4,804,893 +$1,069,026 5,111,588 +29% Nantahala Capital Management, LLC 30 Apr 2025
NORTH RUN CAPITAL, LP 9.3% +86% $3,608,839 +$1,666,000 3,682,489 +86% North Run Capital, LP 31 Mar 2025
SILVERARC CAPITAL MANAGEMENT, LLC 7.8% $2,881,710 3,065,649 SilverArc Capital Management, LLC 31 Dec 2024
LYTTON LAURENCE W 7.2% -14% $4,269,304 -$832,740 2,865,305 -16% Lytton, Laurence W. 30 Sep 2025
Stonepine Capital Management, LLC 6% $2,211,913 2,353,099 Stonepine Capital Management, LLC 31 Dec 2024
HIRSCHMAN ORIN 3.6% -46% $1,331,344 -$1,171,674 1,416,323 -47% Orin Hirschman 31 Mar 2025

As of 31 Dec 2025, 40 institutional investors reported holding 27,571,223 shares of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA). This represents 62% of the company’s total 44,542,200 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Essex Woodlands Management, Inc. 17% 7,714,709 +88% 2.9% $9,103,357
Nantahala Capital Management, LLC 11% 5,111,588 0% 0.36% $6,031,674
SILVERARC CAPITAL MANAGEMENT, LLC 5.9% 2,647,512 -4.9% 0.45% $3,124,064
Stonepine Capital Management, LLC 5.3% 2,352,032 +9.1% 2.2% $2,775,398
VANGUARD GROUP INC 4.1% 1,830,550 +1.7% 0% $2,160,049
UBS Group AG 3.4% 1,500,469 +592% 0% $1,770,553
DAFNA Capital Management LLC 3.2% 1,441,029 0% 0.39% $1,700,414
PERKINS CAPITAL MANAGEMENT INC 3.1% 1,397,418 +68% 1.3% $1,648,953
CITIGROUP INC 1.7% 750,000 0% 0% $885,000
Sio Capital Management, LLC 1.4% 636,300 0% 0.12% $750,834
BlackRock, Inc. 1% 462,353 +0.38% 0% $545,577
GEODE CAPITAL MANAGEMENT, LLC 0.81% 361,498 +1.3% 0% $426,618
WealthTrust Axiom LLC 0.72% 322,588 +39% 0.1% $380,653
NORTHERN TRUST CORP 0.39% 174,398 -0.53% 0% $205,790
RENAISSANCE TECHNOLOGIES LLC 0.29% 128,700 +101% 0% $151,866
Embree Financial Group 0.25% 111,318 +695% 0.02% $131,356
UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC 0.22% 99,888 0% 0.06% $80,989
GSA CAPITAL PARTNERS LLP 0.17% 73,811 -30% 0.01% $87,000
STATE STREET CORP 0.14% 63,383 0% 0% $74,792
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.13% 57,500 0% 0% $67,850
PNC Financial Services Group, Inc. 0.12% 53,612 0% 0% $63,262
Destiny Wealth Partners, LLC 0.12% 52,500 0% 0.01% $50,715
XTX Topco Ltd 0.09% 40,955 0% $48,327
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.08% 37,174 -57% 0% $43,865
RAYMOND JAMES FINANCIAL INC 0.07% 30,200 +50% 0% $35,636

Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 27,571,223 $32,485,316 +$4,138,171 $1.18 40
2025 Q3 23,562,953 $35,108,965 +$70,979 $1.49 40
2025 Q2 23,475,441 $45,542,765 -$775,817 $1.94 45
2025 Q1 24,589,431 $30,000,578 -$5,393,768 $1.22 47
2024 Q4 27,032,996 $81,640,185 +$27,788,571 $3.02 46
2024 Q3 18,012,190 $45,588,967 -$10,956,793 $2.53 48
2024 Q2 19,879,104 $93,430,843 -$6,702,626 $4.70 67
2024 Q1 20,686,484 $117,292,014 -$1,655,166 $5.67 58
2023 Q4 20,961,753 $138,767,513 -$8,011,684 $6.62 59
2023 Q3 21,852,278 $174,816,904 -$1,837,658 $8.00 66
2023 Q2 22,055,151 $223,420,734 +$51,494,354 $10.13 67
2023 Q1 16,939,491 $180,199,912 -$5,749,423 $10.64 54
2022 Q4 17,430,212 $200,446,271 +$6,246,137 $11.50 49
2022 Q3 16,786,563 $143,023,324 +$28,855,257 $8.52 43
2022 Q2 13,534,368 $95,028,004 +$13,917,248 $7.01 31
2022 Q1 11,160,859 $129,798,000 +$6,753,935 $11.63 29
2021 Q4 10,531,506 $134,807,000 -$160,970 $12.80 34
2021 Q3 10,239,091 $139,838,000 -$320,790 $13.66 35
2021 Q2 10,239,149 $164,948,850 +$6,022,396 $16.11 43
2021 Q1 9,891,266 $147,387,000 +$2,988,786 $14.90 46
2020 Q4 9,690,658 $145,766,000 -$988,972 $15.04 47
2020 Q3 9,752,756 $161,293,000 +$2,115,756 $16.54 43
2020 Q2 9,735,757 $126,197,000 +$43,684,111 $12.96 49
2020 Q1 6,476,845 $50,649,000 -$2,643,965 $7.82 26
2019 Q4 6,384,233 $82,677,000 +$79,084,000 $12.95 22